Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
CorrectionCorrection

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study

Adrián Mayo-Juanatey, Santos Castañeda, Vanesa Calvo-Río, Marta Garijo-Bufort, Miriam Retuerto-Guerrero, Marina Salido Olivares and Juan José Alegre-Sancho
The Journal of Rheumatology November 2025, jrheum.2025-0658.C1; DOI: https://doi.org/10.3899/jrheum.2025-0658.C1
Adrián Mayo-Juanatey
A. Mayo-Juanatey, MD, Department of Rheumatology, Hospital Universitari Doctor Peset, Valencia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrián Mayo-Juanatey
Santos Castañeda
S. Castañeda, MD, PhD, Department of Rheumatology, Hospital Universitario de la Princesa, IIS-Princesa, Madrid.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Santos Castañeda
Vanesa Calvo-Río
V. Calvo-Río, MD, PhD, Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanesa Calvo-Río
Marta Garijo-Bufort
M. Garijo-Bufort, MD, PhD, Department of Rheumatology, Hospital de Sagunto, Sagunto, Valencia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marta Garijo-Bufort
Miriam Retuerto-Guerrero
M. Retuerto-Guerrero, MD, PhD, Department of Rheumatology, Complejo Asistencial Universitario de León, León.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miriam Retuerto-Guerrero
Marina Salido Olivares
M. Salido Olivares, MD, PhD, Department of Rheumatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marina Salido Olivares
Juan José Alegre-Sancho
J.J. Alegre-Sancho, MD, PhD, Department of Rheumatology, Hospital Universitari Doctor Peset, Valencia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan José Alegre-Sancho
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

J Rheumatol 2025; doi: 10.3899/jrheum.2025-0658

In the 4th paragraph regarding severe hematological involvement, the criterion for severe leukopenia should be a leukocyte count of < 2 × 109/L. The revised text is "severe leukopenia (leukocyte count < 2 × 109/L)."

This correction applies only to the October 1 First Release. The correct text appears in the print and online issues.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (12)
The Journal of Rheumatology
Vol. 52, Issue 12
1 Dec 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study
Adrián Mayo-Juanatey, Santos Castañeda, Vanesa Calvo-Río, Marta Garijo-Bufort, Miriam Retuerto-Guerrero, Marina Salido Olivares, Juan José Alegre-Sancho
The Journal of Rheumatology Nov 2025, jrheum.2025-0658.C1; DOI: 10.3899/jrheum.2025-0658.C1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study
Adrián Mayo-Juanatey, Santos Castañeda, Vanesa Calvo-Río, Marta Garijo-Bufort, Miriam Retuerto-Guerrero, Marina Salido Olivares, Juan José Alegre-Sancho
The Journal of Rheumatology Nov 2025, jrheum.2025-0658.C1; DOI: 10.3899/jrheum.2025-0658.C1
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study
  • Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024
Show more Correction

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire